This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards

NORTH CHICAGO, Ill., Aug. 18, 2014 /PRNewswire/ --  AbbVie today announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program. Voting for two of the 40 winners to earn the title of 2014 Thriving Undergraduate or Graduate Scholar is now open to the public at www.AbbVieCFScholarship.com until September 15. 

Inspirational stories from students living with CF are spotlighted on the AbbVie CF Scholarship website, www.AbbVieCFScholarship.com. The site also includes instructions on how the public can vote for undergraduate and graduate scholars, by voting either online or texting 23000 with the unique ID provided assigned to the specific scholar (e.g., VOTE1, VOTE2, etc.).

"The achievement and dedication shown by the AbbVie CF Scholarship recipients continue to impress us each year," said Jim Hynd, vice president, GI Care, AbbVie. "Students with CF face significantly more mental, physical and emotional challenges than those who do not suffer the symptoms of this disease, and AbbVie is honored to support their academic endeavors as they become role models for the CF community."

AbbVie is proud to continue the legacy of the CF Scholarship program. Over the course of the 22 years of the scholarship's existence, hundreds of students living with CF have received an estimated $2.4 million in educational funding. 

About Cystic FibrosisCystic fibrosis (CF) is a genetic chronic disease that affects the lungs and digestive systems of approximately 30,000 children and adults in the United States. In patients with CF, a thick, sticky mucus is produced in certain organs throughout the body, most commonly the lungs and digestive system. The mucus build-up in the lungs can cause difficulty breathing and may lead to life-threatening lung infections. In the digestive system, the thick mucus may prevent proper food digestion. More than 75 percent of people with CF are diagnosed by age two.

About the AbbVie CF ScholarshipThe AbbVie CF Scholarship was established 22 years ago in recognition of the financial burdens many families touched by cystic fibrosis (CF) face and to acknowledge the achievements of students with CF. The program has since awarded more than $2.4 million in scholarships. It is not necessary for scholarship applicants to have taken, currently take, or intend to take in the future, any medicine or product marketed by AbbVie, and this is not a consideration in the selection criteria. More information about the AbbVie CF Scholarship criteria and application can be found at www.AbbVieCFScholarship.com.

About AbbVieAbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

SOURCE AbbVie

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs